News
Ultrasound ablation for Parkinson’s disease: Benefit limited by adverse effects
“Longer-term and larger trials are needed to determine the role of focused ultrasound subthalamotomy in the management of Parkinson’s disease.”
News
Which imaging criteria identify progressive forms of MS?
Identification of imaging features associated with primary progressive MS and features that predict evolution from relapsing-remitting MS to...
News
COVID-19 anticoagulation trials ‘paused’ for futility, safety
The trials involved are the REMAP-CAP, ACTIV-4, and ATTACC studies.
News
Disabling stroke reduced with ticagrelor after minor stroke, TIA
“This new information on disabling stroke underlines the importance of getting patients on dual antiplatelet therapy quickly after a TIA or mild...
News
Air pollution linked to brain amyloid pathology
Exposure to air pollution should be considered as one factor in the lifetime risk of developing Alzheimer’s disease.
News
COVID-19 and risk of clotting: ‘Be proactive about prevention’
"We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of...
News
STRENGTH trial questions CV benefit of high-dose omega-3s
Questions about the CV benefit of omega-3 fatty acids and the high-dose eicosapentaenoic acid product, Vascepa, have resurfaced with results of...
News
SCAPIS: Simple questionnaire can identify silent atherosclerosis
The study found 40% of the middle-aged Swedish population without known heart disease had coronary plaques on CCTA, and those with extensive...
News
Local hospitals still have a role in treating severe stroke
Local centers performed very well in the study, with very fast “in/out” times for patients who were subsequently transferred for thrombectomy.
News
NfL blood biomarker captures suboptimal treatment response in MS
“Our data in this well-characterized large real-world cohort supports the value of serum NfL levels for treatment monitoring in MS clinical...
News
A skin test for Parkinson’s disease diagnosis?
The preliminary study used a chemical assay to detect clumping of alpha-synuclein in autopsy skin samples taken from patients who had Parkinson’s...
News
COVID-19: Thromboembolic events high despite prophylaxis
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight...
News
COVID-19 risks are no higher in patients with multiple sclerosis
MS does not appear to be associated with higher risks of severe COVID-19 outcomes compared with the general population.
News
Lower rituximab doses may be as effective, safer in MS
Adverse effects – particularly frequency of infection – were increased in the high-dose group.